Insufficient antibody validation challenges oestrogen receptor beta research

A large body of work into the role of oestrogen receptor b (ERb) in breast cancer is contradictory, hindering future progress. Here the authors conduct extensive validation of anti-ERb antibodies , and show that normal and cancerous breast tissue do not express ERb, consistent with RNA-seq data.

Guardado en:
Detalles Bibliográficos
Autores principales: Sandra Andersson, Mårten Sundberg, Nusa Pristovsek, Ahmed Ibrahim, Philip Jonsson, Borbala Katona, Carl-Magnus Clausson, Agata Zieba, Margareta Ramström, Ola Söderberg, Cecilia Williams, Anna Asplund
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/dcdf449150464c8b9fd9103cfd32d3ef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dcdf449150464c8b9fd9103cfd32d3ef
record_format dspace
spelling oai:doaj.org-article:dcdf449150464c8b9fd9103cfd32d3ef2021-12-02T14:42:40ZInsufficient antibody validation challenges oestrogen receptor beta research10.1038/ncomms158402041-1723https://doaj.org/article/dcdf449150464c8b9fd9103cfd32d3ef2017-06-01T00:00:00Zhttps://doi.org/10.1038/ncomms15840https://doaj.org/toc/2041-1723A large body of work into the role of oestrogen receptor b (ERb) in breast cancer is contradictory, hindering future progress. Here the authors conduct extensive validation of anti-ERb antibodies , and show that normal and cancerous breast tissue do not express ERb, consistent with RNA-seq data.Sandra AnderssonMårten SundbergNusa PristovsekAhmed IbrahimPhilip JonssonBorbala KatonaCarl-Magnus ClaussonAgata ZiebaMargareta RamströmOla SöderbergCecilia WilliamsAnna AsplundNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-14 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Sandra Andersson
Mårten Sundberg
Nusa Pristovsek
Ahmed Ibrahim
Philip Jonsson
Borbala Katona
Carl-Magnus Clausson
Agata Zieba
Margareta Ramström
Ola Söderberg
Cecilia Williams
Anna Asplund
Insufficient antibody validation challenges oestrogen receptor beta research
description A large body of work into the role of oestrogen receptor b (ERb) in breast cancer is contradictory, hindering future progress. Here the authors conduct extensive validation of anti-ERb antibodies , and show that normal and cancerous breast tissue do not express ERb, consistent with RNA-seq data.
format article
author Sandra Andersson
Mårten Sundberg
Nusa Pristovsek
Ahmed Ibrahim
Philip Jonsson
Borbala Katona
Carl-Magnus Clausson
Agata Zieba
Margareta Ramström
Ola Söderberg
Cecilia Williams
Anna Asplund
author_facet Sandra Andersson
Mårten Sundberg
Nusa Pristovsek
Ahmed Ibrahim
Philip Jonsson
Borbala Katona
Carl-Magnus Clausson
Agata Zieba
Margareta Ramström
Ola Söderberg
Cecilia Williams
Anna Asplund
author_sort Sandra Andersson
title Insufficient antibody validation challenges oestrogen receptor beta research
title_short Insufficient antibody validation challenges oestrogen receptor beta research
title_full Insufficient antibody validation challenges oestrogen receptor beta research
title_fullStr Insufficient antibody validation challenges oestrogen receptor beta research
title_full_unstemmed Insufficient antibody validation challenges oestrogen receptor beta research
title_sort insufficient antibody validation challenges oestrogen receptor beta research
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/dcdf449150464c8b9fd9103cfd32d3ef
work_keys_str_mv AT sandraandersson insufficientantibodyvalidationchallengesoestrogenreceptorbetaresearch
AT martensundberg insufficientantibodyvalidationchallengesoestrogenreceptorbetaresearch
AT nusapristovsek insufficientantibodyvalidationchallengesoestrogenreceptorbetaresearch
AT ahmedibrahim insufficientantibodyvalidationchallengesoestrogenreceptorbetaresearch
AT philipjonsson insufficientantibodyvalidationchallengesoestrogenreceptorbetaresearch
AT borbalakatona insufficientantibodyvalidationchallengesoestrogenreceptorbetaresearch
AT carlmagnusclausson insufficientantibodyvalidationchallengesoestrogenreceptorbetaresearch
AT agatazieba insufficientantibodyvalidationchallengesoestrogenreceptorbetaresearch
AT margaretaramstrom insufficientantibodyvalidationchallengesoestrogenreceptorbetaresearch
AT olasoderberg insufficientantibodyvalidationchallengesoestrogenreceptorbetaresearch
AT ceciliawilliams insufficientantibodyvalidationchallengesoestrogenreceptorbetaresearch
AT annaasplund insufficientantibodyvalidationchallengesoestrogenreceptorbetaresearch
_version_ 1718389661797187584